Liposomal formulation of a cytokine restraining agent, (CRA)-HP 228: Encapsulation, stability, and release characteristics

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 4, Issue 2, 1997, Pages 71-74

  Maniar, M ^a   Loullis, C ^a   Dipali, S R ^b   Kulkarni, S B ^b   Betageri, G V ^b  

^a Houghten Pharmaceuticals Inc   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Cytokine; Drug release; Encapsulation; HP 228; Liposome; Stability

Indexed keywords

ALPHA INTERMEDIN DERIVATIVE; ANTIINFLAMMATORY AGENT; CHOLESTEROL; CHYMOTRYPSIN; DICETYL PHOSPHATE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; HEPTAPEPTIDE; HP 228; LIPOSOME; POLYCARBONATE; PROTAMINE; TRYPSIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG FORMULATION; DRUG STABILITY; ELECTRICITY; ENCAPSULATION; HYDRATION; PARTICLE SIZE; PH; PRIORITY JOURNAL;

EID: 0030985838     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549709051875     Document Type: Article

References (11)

1. Betageri, G. V., Jenkins, S. A., and Parsons, D. L. (1993) Pharmacokinetics of liposome products. In Liposome Drug Delivery Systems, 47-64. Lancaster, PA: Technomic Publishing.
2. Devillier, P., Drapeau, G., Renoux, M., and Regoli, D. (1989) Role of the N-terminal arginine in the histamine releasing activity of substance P, bradykinin and related peptides. Eur. J. Pharmacol. 168, 53-60.
3. Eichler, J., Appel, J., Blondelle, S., Dooley, C., Dorner, B., Ostresh, J., Perez-Paya, E., Pinilla, C., and Houghten R. (1995) Peptide, peptidometric and organic synthetic combinatorial libraries. Med. Res. Rev. 15, 481-496.
4. Houghten Pharmaceuticals, Inc. (1995) Cytokine restraining agents. U.S. patent 5420109.
5. Hwang, K. J. (1987) Liposome pharmacokinetics. In Liposomes: From Biophysics to Therapeutics, ed. M. J. Ostro, 109-156. New York: Marcel Dekker.
6. Kulkarni, S. B., Dipali, S. R., and Betageri, G. V. (1995) Protamine induced aggregation of unilamellar liposomes. Pharm. Sci. 1, 359-362.
7. Loullis, C., Basu, A., Garcia, A., Frazer, J., Robison, A., and Tuttle, R. (1995) Rising dose safety and tolerance of HP 228 in normal male volunteers. Pharm. Res. 12, S392.
8. Park, E., Shah, J., and Maniar, M. (1993) Development of an in vitro release method for microparticulate drug delivery system. Pharm. Res. 10, S189.
9. Patel, H. M. (1988) Liposomes in the lymphatics. In Liposomes as Drug Carriers, ed. G. Gregoriadis, 51-62. New York: John Wiley & Sons.
10. Schoofs, L., Deloof, A., Matsumoto, S., Jagou, S., and Vaudry, H. (1993) The melanotropic peptides in insects. Ann. N. Y. Acad. Sci. 680, 600-602.
11. Venkatarangan, A., Taft, D., Maniar, M., and Simonelli, A. (1995) Determination of apparent pKa's of HP 228, a novel polypeptide, and correlation to its partitioning behavior. Pharm. Res. 12, S82.